A minimum age for measles vaccine administration to coloured children.
The antibody response to further-attenuated live virus measles vaccine was assessed in 67 Coloured children between the ages of 6 and 12 months. Children less than 9 months of age were found to have suboptimal seroconversion rates and it is recommended that the routine administration of measles vaccine should be restricted to children over the age of 8 months. High-risk groups and problems of vaccine administration and storage are discussed.
D001741:Black or African American; D000367:Age Factors; D000914:Antibodies, Viral / Q000032:analysis*; D000917:Antibody Formation; D044383:Black People; D003168:Complement Fixation Tests; D006801:Humans; D007223:Infant; D008457:Measles / Q000517:prevention & control; D008458:Measles Vaccine / Q000008:administration & dosage*; D008459:Measles virus / Q000276:immunology*; D013019:South Africa; D014611:Vaccination / Q000009:adverse effects; D014613:Vaccines, Attenuated / Q000008:administration & dosage
D000914:Antibodies, Viral; D008458:Measles Vaccine; D014613:Vaccines, Attenuated